Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 June 2018

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Date

Pirmdiena, 11 Jūnijs 2018, Visu dienu

Vieta

European Medicines Agency, Amsterdam, the Netherlands

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

български (BG) (254.09 KB - PDF)

Skatīt

español (ES) (223.77 KB - PDF)

Skatīt

čeština (CS) (245.83 KB - PDF)

Skatīt

dansk (DA) (220.97 KB - PDF)

Skatīt

Deutsch (DE) (225.02 KB - PDF)

Skatīt

eesti (ET) (219.98 KB - PDF)

Skatīt

ελληνικά (EL) (260.1 KB - PDF)

Skatīt

français (FR) (225.33 KB - PDF)

Skatīt

hrvatski (HR) (239.57 KB - PDF)

Skatīt

italiano (IT) (222.54 KB - PDF)

Skatīt

latviešu (LV) (252.56 KB - PDF)

Skatīt

lietuvių (LT) (244.9 KB - PDF)

Skatīt

magyar (HU) (246.89 KB - PDF)

Skatīt

Malti (MT) (250.25 KB - PDF)

Skatīt

Nederlands (NL) (223.78 KB - PDF)

Skatīt

polski (PL) (249.58 KB - PDF)

Skatīt

português (PT) (224.7 KB - PDF)

Skatīt

română (RO) (248.09 KB - PDF)

Skatīt

slovenčina (SK) (244.56 KB - PDF)

Skatīt

slovenščina (SL) (241.23 KB - PDF)

Skatīt

suomi (FI) (222.25 KB - PDF)

Skatīt

svenska (SV) (221.21 KB - PDF)

Skatīt

Multimedia

The PRAC held a public hearing on quinolone and fluoroquinolone antibiotics on 13 June 2018.

The hearing was broadcast live on 13 June from 13:00 - 18:00 (UK time).

The video recording is available.

Share this page